| The molecular defect leading to Fabry disease: structure of human α-galactosidase SC Garman, DN Garboczi Journal of molecular biology 337 (2), 319-335, 2004 | 562 | 2004 |
| Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα SC Garman, BA Wurzburg, SS Tarchevskaya, JP Kinet, TS Jardetzky Nature 406 (6793), 259-266, 2000 | 514 | 2000 |
| The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags DN Hebert, SC Garman, M Molinari Trends in cell biology 15 (7), 364-370, 2005 | 334 | 2005 |
| Pediatric fabry disease M Ries, S Gupta, DF Moore, V Sachdev, JM Quirk, GJ Murray, DR Rosing, ... Pediatrics 115 (3), e344-e355, 2005 | 296 | 2005 |
| Crystal structure of the human high-affinity IgE receptor SC Garman, JP Kinet, TS Jardetzky Cell 95 (7), 951-961, 1998 | 224 | 1998 |
| Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: Biochemical characterization and restoration of normal intracellular … S Ishii, HH Chang, K Kawasaki, K Yasuda, HL Wu, SC Garman, JQ Fan Biochemical Journal 406 (2), 285-295, 2007 | 189 | 2007 |
| GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings A Caciotti, SC Garman, Y Rivera-Colón, E Procopio, S Catarzi, L Ferri, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (7), 782-790, 2011 | 186 | 2011 |
| CATALYTIC MECHANISM OF HUMAN Α-GALACTOSIDASE AI Guce, NE Clark, EN Salgado, DR Ivanen, AA Kulminskaya, H Brumer, ... Journal of Biological Chemistry 285 (6), 3625-3632, 2010 | 170 | 2010 |
| Poor immunogenicity of a self/tumor antigen derives from peptide–MHC-I instability and is independent of tolerance Z Yu, MR Theoret, CE Touloukian, DR Surman, SC Garman, ... The Journal of clinical investigation 114 (4), 551-559, 2004 | 157 | 2004 |
| The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A Y Rivera-Colón, EK Schutsky, AZ Kita, SC Garman Journal of molecular biology 423 (5), 736-751, 2012 | 137 | 2012 |
| Structure of the human IgE-Fc Cε3-Cε4 reveals conformational flexibility in the antibody effector domains BA Wurzburg, SC Garman, TS Jardetzky Immunity 13 (3), 375-385, 2000 | 133 | 2000 |
| The 1.9 Å structure of α-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases SC Garman, L Hannick, A Zhu, DN Garboczi Structure 10 (3), 425-434, 2002 | 113 | 2002 |
| Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study DP Germain, E Brand, A Burlina, F Cecchi, SC Garman, J Kempf, ... Molecular genetics & genomic medicine 6 (4), 492-503, 2018 | 104 | 2018 |
| Structural basis of Fabry disease SC Garman, DN Garboczi Molecular genetics and metabolism 77 (1-2), 3-11, 2002 | 103 | 2002 |
| The alpha-galactosidase A p. Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies S Ferreira, A Ortiz, DP Germain, M Viana-Baptista, A Caldeira-Gomes, ... Molecular genetics and metabolism 114 (2), 248-258, 2015 | 102 | 2015 |
| The molecular basis of pharmacological chaperoning in human α-galactosidase AI Guce, NE Clark, JJ Rogich, SC Garman Chemistry & biology 18 (12), 1521-1526, 2011 | 97 | 2011 |
| Structure–function relationships in α‐galactosidase A SC Garman Acta Paediatrica 96, 6-16, 2007 | 97 | 2007 |
| The 1.51-Å structure of the poxvirus L1 protein, a target of potent neutralizing antibodies HP Su, SC Garman, TJ Allison, C Fogg, B Moss, DN Garboczi Proceedings of the National Academy of Sciences 102 (12), 4240-4245, 2005 | 90 | 2005 |
| Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution RW Herbst, A Guce, PA Bryngelson, KA Higgins, KC Ryan, DE Cabelli, ... Biochemistry 48 (15), 3354-3369, 2009 | 81 | 2009 |
| The 1.9 Å structure of human α-N-acetylgalactosaminidase: the molecular basis of Schindler and Kanzaki diseases NE Clark, SC Garman Journal of molecular biology 393 (2), 435-447, 2009 | 75 | 2009 |
